Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice
Keywords: اپرگلیفلوزین; SGLT2 inhibitor; Ipragliflozin; Hyperglycemia; Type 2 diabetes; Nephropathy;